United States · FDA National Drug Code directory
ZYNRELEF
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47426-501_ab2a0921-41d7-4b3b-ace9-6adccb12c5e9
- Product NDC
- 47426-501
- Form
- SOLUTION
- Composition / generic term
- BUPIVACAINE and MELOXICAM
- Labeler
- Heron Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241201
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPIVACAINE — 400 mg/14mL
- MELOXICAM — 12 mg/14mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 KIT (47426-501-02) / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-501-04) / 14 mL in 1 VIAL, SINGLE-DOSE · 47426-501-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →